Clinical Trial Finds Zolinza Effective for B-cell Non-Hodgkin's Lymphoma ... PR Web (press release) Although certain B-cell Non-Hodgkin's Lymphomas, such as follicular lymphoma, may initially respond well to rituximab-based chemotherapy, the cancer often returns. This tendency to relapse is why follicular lymphoma is considered incurable. In the ... |
